Acrylic Acid

Acrylic Acid

SCHEMBL638940

C=CC(=O)O.Cl.N.N

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acrylic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acrylic Acid SCHEMBL638942 1.00
Acrylic Acid SCHEMBL5088209 0.96 LMNA (0.91)
Acrylic Acid SCHEMBL8852653 0.96
Acrylic Acid SCHEMBL11650689 0.96 LMNA (0.91)
Acrylic Acid SCHEMBL337661 0.96
Acrylic Acid SCHEMBL1707147 0.96
Acrylic Acid SCHEMBL6322904 0.96
Acrylic Acid SCHEMBL10552280 0.96 LMNA (0.91)
Acrylic Acid SCHEMBL56459 0.96
Acrylic Acid SCHEMBL8377395 0.96 LMNA (0.91)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114105626-B Preparation method of wet-pressure magnetic shoe 安徽龙磁科技股份有限公司 2022-09-02 CN claimed
CN-114105626-A Preparation method of wet-pressure magnetic shoe 安徽龙磁科技股份有限公司 2022-03-01 CN claimed
US-20230404896-A1 Styling Shampoo Compositions BASF SE (DE) 2023-12-21 US disclosed
EP-4240316-A1 STYLING SHAMPOO COMPOSITIONS BASF SE (DE) 2023-09-13 EP disclosed
CN-114105626-B Preparation method of wet-pressure magnetic shoe 安徽龙磁科技股份有限公司 2022-09-02 CN disclosed
WO-2022096243-A1 STYLING SHAMPOO COMPOSITIONS BASF SE (DE) 2022-05-12 WO disclosed
CN-114105626-A Preparation method of wet-pressure magnetic shoe 安徽龙磁科技股份有限公司 2022-03-01 CN disclosed
US-10335358-B2 Hair cosmetic KAO CORPORATION (JP) 2019-07-02 US disclosed
EP-2332583-B1 ANTIVIRAL DISINFECTANTS AND THEIR APPLICATIONS GOJO IND INC (US) 2018-12-19 EP disclosed
CN-108883046-A Personal care composition and the method for using such composition 罗地亚经营管理公司 2018-11-23 CN disclosed
US-10130655-B2 Composition and method for pre-surgical skin disinfection GOJO INDUSTRIES, INC. (US) 2018-11-20 US disclosed
US-20080207767-A1 Foamable Alcoholic Composition SILVER POINT FINANCE, LLC, AS COLLATERAL AGENT 2008-08-28 US disclosed
WO-2007095008-A2 ANTIVIRAL DISINFECTANTS AND APPLICATIONS GOJO INDUSTRIES, INC. (US) 2007-08-23 WO disclosed
EP-1820396-A1 Composition and method for pre-surgical skin disinfection Gojo Industries, Inc. (US) 2007-08-22 EP disclosed
US-20070185216-A1 ANTIVIRAL METHOD PNC BANK, NATIONAL ASSOCIATION, AS AGENT 2007-08-09 US disclosed
US-20070184013-A1 Antiviral method SILVER POINT FINANCE, LLC, AS COLLATERAL AGENT 2007-08-09 US disclosed
US-20070184016-A1 Composition and method for pre-surgical skin disinfection SILVER POINT FINANCE, LLC, AS COLLATERAL AGENT 2007-08-09 US disclosed
EP-1811013-A1 Foamable alcoholic composition Gojo Industries, Inc. (US) 2007-07-25 EP disclosed
US-20070148101-A1 Foamable alcoholic composition GOJO INDUSTRIES, INC. 2007-06-28 US disclosed
US-5858939-A PREPARING A DETERGENT BAR COMPOSITION HAVING ENHANCED DEPOSITION OF A BENEFIT AGENT AND DEPOSITION POLYMER LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) 1999-01-12 US disclosed